Immune checkpoint inhibitor toxicity and associated outcomes in a geriatric population.

被引：0
|
作者：
Polewski, Peter James
Hayashi-Tanner, Yacki
Gaddam, Mamatha
Fisher, Nancy R.
Kovacs, Attila J.
Marinier, David E.
机构：
[1] Gundersen Hlth Syst, La Crosse, WI USA
[2] Gundersen H, La Crosse, WI USA
[3] Gunderson Med Fdn, La Crosse, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24014
引用
收藏
页数：1
相关论文
共 50 条
  • [21] IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS
    Abdolall, Ali K.
    Srivastava, Geetika
    Abdelnour, John
    Balakumaran, Kathir
    Aneja, Ashish
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3482 - 3482
  • [22] Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities
    Wu, Nan-Chun
    Feng, Yin-Hsun
    Kuo, Yu Hsuan
    Chen, Wei-Yu
    Wu, Hong-Chang
    Huang, Chien-Tai
    Wang, Wen-Ching
    Kang, Nai-Wen
    Shih, Jhih-Yuan
    Chen, Zhih-Cherng
    Chang, Wei-Ting
    ACTA CARDIOLOGICA SINICA, 2022, 38 (01) : 39 - 46
  • [23] Clinical Characteristics and Outcomes in Immune Checkpoint Inhibitor Therapy-Associated Myocarditis
    Thakker, Ravi A.
    Lee, Marissa A.
    Albaeni, Aiham
    Elbadawi, Ayman
    Suthar, Krishna H.
    Perez, Christopher
    Sonstein, Lindsay K.
    Farr, Norman M.
    Venkatesan, Rohit
    Khalife, Wissam
    Berbarie, Rafic F.
    Chatila, Khaled F.
    CARDIOLOGY RESEARCH, 2021, 12 (05) : 270 - 278
  • [24] ECHOCARDIOGRAPHIC FEATURES OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS AND THEIR ASSOCIATION WITH ADVERSE OUTCOMES
    Orimoloye, Olusola
    Power, John R.
    Nowatzke, Joseph
    Hughes, Andrew M.
    Lehmann, Lorenz
    Cautela, Jennifer
    Aras, Mandar
    Weppler, Alison
    Narezkina, Anna
    Peretto, Giovanni
    Pela, Michal
    Crusz, Shanthini M.
    Asnani, Aarti
    Salem, Joe-Elie
    Deswal, Anita
    Palaskas, Nicolas
    Moslehi, Javid
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3336 - 3336
  • [25] Molecular analysis of immune checkpoint inhibitor associated erythema nodosum-like toxicity
    Sun, Xiaopeng
    Axelrod, Margaret L.
    Gonzalez-Ericsson, Paula I.
    Sanchez, Violeta
    Wang, Yu
    Curry, Jonathan L.
    Phillips, Elizabeth J.
    Xu, Yaomin
    Johnson, Douglas B.
    Balko, Justin M.
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [26] Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy
    Cone, Eugene B.
    Haeuser, Lorine
    Reese, Stephen W.
    Marchese, Maya
    Nguyen, David-Dan
    Nabi, Junaid
    Chou, Wesley H.
    Noldus, Joachim
    McKay, Rana R.
    Kilbridge, Kerry Laing
    Quoc-Dien Trinh
    PLOS ONE, 2022, 17 (11):
  • [27] Toxicity patterns associated with chemotherapy/immune checkpoint inhibitor combinations: a meta-analysis
    Abdel-Rahman, Omar
    IMMUNOTHERAPY, 2019, 11 (06) : 543 - 554
  • [28] Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor
    Rocha, Marta
    de Sousa, Joao Correia
    Salgado, Marta
    Araujo, Antonio
    Pedroto, Isabel
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2019, 26 (04) : 268 - 274
  • [29] Oral toxicity associated with checkpoint inhibitor immunotherapy
    Chiang, P.
    Chen, C.
    Chen, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (09) : B25 - B25
  • [30] Timing of steroid use and outcomes of immune checkpoint inhibitor: A population based study.
    Nikita, Nikita
    Johnson, Jennifer Maria
    Wilson, Melissa
    Banks, Joshua
    Keith, Scott W.
    Sharma, Swapnil
    Lu-Yao, Grace L.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345